Ozempic and other kinds of GLP-1 medications have skyrocketed in popularity in recent years, but the likelihood of you or your neighbor being on the weight loss drugs could vary significantly based on where you live.

In a recent report from weight loss management platform Levity, cities were ranked by Google search trends for the medications based on how interested residents were in the drugs.

Why It Matters

The use of glucagon-like peptide-1 (GLP-1) receptor agonists has surged, and popular products like Ozempic, Mounjaro, Wegovy and Zephound have been a game changer for many Americans who are obese or have type 2 diabetes.

While the drugs have been linked to successful short term weight loss, they also have a large number of side effects, including nausea, vomiting, diarrhea,

See Full Page